Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Inspire Medical Systems, Inc.INSP · Entity 1186 | Director · CEO and President | February 20, 2026 | February 25, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Inspire Medical Systems, Inc.
Report date February 20, 2026 · Filed February 25, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 99,834 |
Ending reported balance
After 2026-02-20 transaction · row 3
3 source rows · reconciled sequenceRow 1 · 2026-02-20 · Grant · Acquired 9,005 · Balance 41,691 F1: Reflects an award of shares of common stock following the satisfaction of performance conditions associated with previously granted performance stock units. Row 2 · 2026-02-20 · Tax withholding · Disposed 4,010 · Balance 37,681 F2: Reflects shares of common stock that were withheld by the Issuer to satisfy taxes incident to vesting of a performance stock unit award. Row 3 · 2026-02-20 · Grant · Acquired 62,153 · Balance 99,834 F3: Represents an award of restricted stock units ("RSUs"), which vests in three equal annual installments commencing on February 20, 2027. Each RSU represents a contingent right to receive one share of Issuer's common stock, subject to the Reporting Person's continuous employment with the Issuer through the relevant dates. |
| Common StockSEC Table I · non-derivative | IndirectBy Trust | 63,658 |
Reported balance
Holding disclosure · report date 2026-02-20 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 63,658 F4: Securities held by the Timothy P. Herbert 2018 Family Continuation Trust c/u the Timothy P. Herbert 2018 Grantor Retained Annuity Trust. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects an award of shares of common stock following the satisfaction of performance conditions associated with previously granted performance stock units.
F2: Reflects shares of common stock that were withheld by the Issuer to satisfy taxes incident to vesting of a performance stock unit award.
F3: Represents an award of restricted stock units ("RSUs"), which vests in three equal annual installments commencing on February 20, 2027. Each RSU represents a contingent right to receive one share of Issuer's common stock, subject to the Reporting Person's continuous employment with the Issuer through the relevant dates.
F4: Securities held by the Timothy P. Herbert 2018 Family Continuation Trust c/u the Timothy P. Herbert 2018 Grantor Retained Annuity Trust.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 08, 2023 Filed Sep 13, 2023 20:14 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleStock Option (Right to Buy) · Derivative | 23,361 | Not disclosed Strike: $42.15 | Not disclosed |
DisclosureSEC source: 0001104659-23-100460 · tm2326030-1_4seq1.xml · derivative · entry 17 Herbert Timothy P. · CIK 0001737136 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Indirect · By LLC Disclosed balance after: 51,913 Underlying: Common Stock · 23,361 shares Expires 2028-12-18 F4 · price: The sale price of the transaction described in footnote (3) will be subsequently determined by a third-party valuation firm. F7 · derivative.exercise_date: The option is fully vested and exercisable. F3 · balance_after: On September 8, 2023, the TPH 2022 LLC sold 45% of its non-voting membership units. The total amount of securities reported remains unchanged because the Reporting Person continues to have a pecuniary interest in the securities held by the TPH 2022 LLC. Read SEC document |
| September 08, 2023 Filed Sep 13, 2023 20:14 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleStock Option (Right to Buy) · Derivative | 9,793 | Not disclosed Strike: $10.38 | Not disclosed |
DisclosureSEC source: 0001104659-23-100460 · tm2326030-1_4seq1.xml · derivative · entry 16 Herbert Timothy P. · CIK 0001737136 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Indirect · By LLC Disclosed balance after: 21,762 Underlying: Common Stock · 9,793 shares Expires 2028-04-08 F4 · price: The sale price of the transaction described in footnote (3) will be subsequently determined by a third-party valuation firm. F7 · derivative.exercise_date: The option is fully vested and exercisable. F3 · balance_after: On September 8, 2023, the TPH 2022 LLC sold 45% of its non-voting membership units. The total amount of securities reported remains unchanged because the Reporting Person continues to have a pecuniary interest in the securities held by the TPH 2022 LLC. Read SEC document |
| September 08, 2023 Filed Sep 13, 2023 20:14 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GiftStock Option (Right to Buy) · Derivative | 2,499 | $0.00 Strike: $227.53 | $0.00 |
DisclosureSEC source: 0001104659-23-100460 · tm2326030-1_4seq1.xml · derivative · entry 14 Herbert Timothy P. · CIK 0001737136 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Indirect · By LLC Disclosed balance after: 5,553 Underlying: Common Stock · 2,499 shares Expires 2030-12-14 F10 · derivative.exercise_date: The grant of options to purchase 17,773 shares of common stock vested and became exercisable as to 25% of the underlying shares on the first anniversary of February 11, 2022 and the remaining 75% of the underlying shares have vested or will vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates. F2 · balance_after: The securities reflected herein as owned by the LLC were previously reported as directly owned by the Reporting Person. On September 8, 2023, the TPH 2022 LLC, an entity fully controlled by, and entirely for the benefit of, the Reporting Person gifted 45% of its non-voting membership units to the Reporting Person's spouse. TPH 2022 LLC holds securities for the benefit of its members. The total amount of securities reported remains unchanged because the Reporting Person continues to have a pecuniary interest in the securities held by the TPH 2022 LLC. Read SEC document |
| September 08, 2023 Filed Sep 13, 2023 20:14 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GiftStock Option (Right to Buy) · Derivative | 11,745 | $0.00 Strike: $194.82 | $0.00 |
DisclosureSEC source: 0001104659-23-100460 · tm2326030-1_4seq1.xml · derivative · entry 12 Herbert Timothy P. · CIK 0001737136 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Indirect · By LLC Disclosed balance after: 26,100 Underlying: Common Stock · 11,745 shares Expires 2030-12-14 F9 · derivative.exercise_date: The grant of options to purchase 43,200 shares of common stock vested and became exercisable as to 25% of the underlying shares on the first anniversary of December 14, 2020 and the remaining 75% of the underlying shares have vested or will vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates. F2 · balance_after: The securities reflected herein as owned by the LLC were previously reported as directly owned by the Reporting Person. On September 8, 2023, the TPH 2022 LLC, an entity fully controlled by, and entirely for the benefit of, the Reporting Person gifted 45% of its non-voting membership units to the Reporting Person's spouse. TPH 2022 LLC holds securities for the benefit of its members. The total amount of securities reported remains unchanged because the Reporting Person continues to have a pecuniary interest in the securities held by the TPH 2022 LLC. Read SEC document |
| September 08, 2023 Filed Sep 13, 2023 20:14 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GiftStock Option (Right to Buy) · Derivative | 24,720 | $0.00 Strike: $71.00 | $0.00 |
DisclosureSEC source: 0001104659-23-100460 · tm2326030-1_4seq1.xml · derivative · entry 10 Herbert Timothy P. · CIK 0001737136 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Indirect · By LLC Disclosed balance after: 54,934 Underlying: Common Stock · 24,720 shares Expires 2029-12-16 F8 · derivative.exercise_date: The original grant of options to purchase 65,000 shares of common stock vested and became exercisable as to 25% of the underlying shares on the first anniversary of December 16, 2019 and the remaining 75% of the underlying shares have vested or will vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates. F2 · balance_after: The securities reflected herein as owned by the LLC were previously reported as directly owned by the Reporting Person. On September 8, 2023, the TPH 2022 LLC, an entity fully controlled by, and entirely for the benefit of, the Reporting Person gifted 45% of its non-voting membership units to the Reporting Person's spouse. TPH 2022 LLC holds securities for the benefit of its members. The total amount of securities reported remains unchanged because the Reporting Person continues to have a pecuniary interest in the securities held by the TPH 2022 LLC. Read SEC document |
| September 08, 2023 Filed Sep 13, 2023 20:14 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GiftStock Option (Right to Buy) · Derivative | 23,361 | $0.00 Strike: $42.15 | $0.00 |
DisclosureSEC source: 0001104659-23-100460 · tm2326030-1_4seq1.xml · derivative · entry 8 Herbert Timothy P. · CIK 0001737136 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Indirect · By LLC Disclosed balance after: 51,913 Underlying: Common Stock · 23,361 shares Expires 2028-12-18 F7 · derivative.exercise_date: The option is fully vested and exercisable. F2 · balance_after: The securities reflected herein as owned by the LLC were previously reported as directly owned by the Reporting Person. On September 8, 2023, the TPH 2022 LLC, an entity fully controlled by, and entirely for the benefit of, the Reporting Person gifted 45% of its non-voting membership units to the Reporting Person's spouse. TPH 2022 LLC holds securities for the benefit of its members. The total amount of securities reported remains unchanged because the Reporting Person continues to have a pecuniary interest in the securities held by the TPH 2022 LLC. Read SEC document |
| September 08, 2023 Filed Sep 13, 2023 20:14 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GiftStock Option (Right to Buy) · Derivative | 9,793 | $0.00 Strike: $10.38 | $0.00 |
DisclosureSEC source: 0001104659-23-100460 · tm2326030-1_4seq1.xml · derivative · entry 6 Herbert Timothy P. · CIK 0001737136 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Indirect · By LLC Disclosed balance after: 21,762 Underlying: Common Stock · 9,793 shares Expires 2028-04-08 F7 · derivative.exercise_date: The option is fully vested and exercisable. F2 · balance_after: The securities reflected herein as owned by the LLC were previously reported as directly owned by the Reporting Person. On September 8, 2023, the TPH 2022 LLC, an entity fully controlled by, and entirely for the benefit of, the Reporting Person gifted 45% of its non-voting membership units to the Reporting Person's spouse. TPH 2022 LLC holds securities for the benefit of its members. The total amount of securities reported remains unchanged because the Reporting Person continues to have a pecuniary interest in the securities held by the TPH 2022 LLC. Read SEC document |
| September 08, 2023 Filed Sep 13, 2023 20:14 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 47,992 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-23-100460 · tm2326030-1_4seq1.xml · nonDerivative · entry 2 Herbert Timothy P. · CIK 0001737136 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Indirect · By LLC Disclosed balance after: 106,651 F3 · shares: On September 8, 2023, the TPH 2022 LLC sold 45% of its non-voting membership units. The total amount of securities reported remains unchanged because the Reporting Person continues to have a pecuniary interest in the securities held by the TPH 2022 LLC. F4 · price: The sale price of the transaction described in footnote (3) will be subsequently determined by a third-party valuation firm. F3 · balance_after: On September 8, 2023, the TPH 2022 LLC sold 45% of its non-voting membership units. The total amount of securities reported remains unchanged because the Reporting Person continues to have a pecuniary interest in the securities held by the TPH 2022 LLC. Read SEC document |
| September 08, 2023 Filed Sep 13, 2023 20:14 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GiftCommon Stock | 47,992 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-100460 · tm2326030-1_4seq1.xml · nonDerivative · entry 1 Herbert Timothy P. · CIK 0001737136 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Indirect · By LLC Disclosed balance after: 106,651 F2 · shares: The securities reflected herein as owned by the LLC were previously reported as directly owned by the Reporting Person. On September 8, 2023, the TPH 2022 LLC, an entity fully controlled by, and entirely for the benefit of, the Reporting Person gifted 45% of its non-voting membership units to the Reporting Person's spouse. TPH 2022 LLC holds securities for the benefit of its members. The total amount of securities reported remains unchanged because the Reporting Person continues to have a pecuniary interest in the securities held by the TPH 2022 LLC. F1 · balance_after: On the Reporting Person's Form 4 dated August 28, 2023, the Reporting Person reported a gift transaction using shares directly held, that should have been reported with shares held by the Timothy P. Herbert 2013 Family Irrevocable GST Trust U/A/D November 27, 2013. F2 · balance_after: The securities reflected herein as owned by the LLC were previously reported as directly owned by the Reporting Person. On September 8, 2023, the TPH 2022 LLC, an entity fully controlled by, and entirely for the benefit of, the Reporting Person gifted 45% of its non-voting membership units to the Reporting Person's spouse. TPH 2022 LLC holds securities for the benefit of its members. The total amount of securities reported remains unchanged because the Reporting Person continues to have a pecuniary interest in the securities held by the TPH 2022 LLC. Read SEC document |
| August 24, 2023 Filed Aug 29, 2023 01:14 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GiftCommon Stock | 3,224 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-096144 · tm2324852-2_4seq1.xml · nonDerivative · entry 1 Herbert Timothy P. · CIK 0001737136 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 104,560 Read SEC document |
| August 23, 2023 Filed Aug 28, 2023 12:03 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionStock Option (Right to Buy) · Derivative | 15 | $0.00 Strike: $42.15 | $0.00 |
DisclosureSEC source: 0001104659-23-095629 · tm2324852-1_4seq1.xml · derivative · entry 6 Herbert Timothy P. · CIK 0001737136 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,913 Underlying: Common Stock · 15 shares Expires 2028-12-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The option is fully vested and exercisable. F6 · balance_after: A portion of this award is now held by the Timothy P. Herbert 2013 Family Irrevocable GST Trust U/A/D November 27, 2013 and the total held directly by the Reporting Person has been updated accordingly. Read SEC document |
| August 23, 2023 Filed Aug 28, 2023 12:03 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionStock Option (Right to Buy) · Derivative | 938 | $0.00 Strike: $71.00 | $0.00 |
DisclosureSEC source: 0001104659-23-095629 · tm2324852-1_4seq1.xml · derivative · entry 5 Herbert Timothy P. · CIK 0001737136 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 64,062 Underlying: Common Stock · 938 shares Expires 2029-12-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The original grant of options to purchase 65,000 shares of common stock vested and became exercisable as to 25% of the underlying shares on the first anniversary of December 16, 2019 and the remaining 75% of the underlying shares have vested or will vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates. Read SEC document |
| August 23, 2023 Filed Aug 28, 2023 12:03 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionCommon Stock | 15 | $42.15 | $632.25 |
DisclosureSEC source: 0001104659-23-095629 · tm2324852-1_4seq1.xml · nonDerivative · entry 2 Herbert Timothy P. · CIK 0001737136 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 107,784 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 23, 2023 Filed Aug 28, 2023 12:03 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionCommon Stock | 938 | $71.00 | $66,598.00 |
DisclosureSEC source: 0001104659-23-095629 · tm2324852-1_4seq1.xml · nonDerivative · entry 1 Herbert Timothy P. · CIK 0001737136 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 107,769 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 58 additional shares acquired under the Inspire Medical Systems, Inc. 2018 Employee Stock Purchase Plan. Read SEC document |
| February 15, 2023 Filed Mar 13, 2023 20:51 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 11,715 | $275.17 | $3,223,616.55 |
DisclosureSEC source: 0001104659-23-031810 · tm239130-3_4seq1.xml · nonDerivative · entry 24 Herbert Timothy P. · CIK 0001737136 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Indirect · By family trust Disclosed balance after: 17,889 F9 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F12 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $275.00 to $275.94, inclusive. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: Securities held by the Margaret C. Herbert 2018 Family Irrevocable GST Trust. Read SEC document |
| February 14, 2023 Filed Mar 13, 2023 20:51 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 1,496 | $276.18 | $413,165.28 |
DisclosureSEC source: 0001104659-23-031810 · tm239130-3_4seq1.xml · nonDerivative · entry 23 Herbert Timothy P. · CIK 0001737136 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Indirect · By family trust Disclosed balance after: 29,604 F9 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F11 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $276.00 to $276.43, inclusive. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: Securities held by the Margaret C. Herbert 2018 Family Irrevocable GST Trust. Read SEC document |
| February 14, 2023 Filed Mar 13, 2023 20:51 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 18,642 | $275.47 | $5,135,311.74 |
DisclosureSEC source: 0001104659-23-031810 · tm239130-3_4seq1.xml · nonDerivative · entry 22 Herbert Timothy P. · CIK 0001737136 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Indirect · By family trust Disclosed balance after: 31,100 F9 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F10 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $275.00 to $275.96, inclusive. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: Securities held by the Margaret C. Herbert 2018 Family Irrevocable GST Trust. Read SEC document |
| February 13, 2023 Filed Feb 15, 2023 00:51 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 2,619 | $275.05 | $720,355.95 |
DisclosureSEC source: 0001104659-23-022076 · tm236006-4_4seq1.xml · nonDerivative · entry 1 Herbert Timothy P. · CIK 0001737136 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Indirect · By family trust Disclosed balance after: 9,728 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $275.00 to $275.19, inclusive. The Reporting Person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: Shares held by the Margaret C. Herbert 2018 Family Irrevocable GST Trust. Read SEC document |
| February 10, 2023 Filed Feb 15, 2023 00:51 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GrantEmployee Stock Option (Right to Buy) · Derivative | 20,439 | $0.00 Strike: $263.16 | $0.00 |
DisclosureSEC source: 0001104659-23-022076 · tm236006-4_4seq1.xml · derivative · entry 6 Herbert Timothy P. · CIK 0001737136 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,439 Underlying: Common Stock · 20,439 shares Expires 2033-02-10 F7 · derivative.exercise_date: The option vests and becomes exercisable as to 25% of the underlying shares on the first anniversary of February 10, 2023 and the remaining 75% of the underlying shares in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates. Read SEC document |
| February 09, 2023 Filed Feb 10, 2023 23:36 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 7,028 | $275.12 | $1,933,543.36 |
DisclosureSEC source: 0001104659-23-018715 · tm236006-2_4seq1.xml · nonDerivative · entry 3 Herbert Timothy P. · CIK 0001737136 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Indirect · By family trust Disclosed balance after: 12,347 F2 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $275.00 to $275.61, inclusive. The Reporting Person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: Shares held by the Margaret C. Herbert 2018 Family Irrevocable GST Trust. Read SEC document |
| February 08, 2023 Filed Feb 10, 2023 23:36 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 3,500 | $275.00 | $962,500.00 |
DisclosureSEC source: 0001104659-23-018715 · tm236006-2_4seq1.xml · nonDerivative · entry 2 Herbert Timothy P. · CIK 0001737136 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Indirect · By family trust Disclosed balance after: 19,375 F2 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F3 · ownership.nature: Shares held by the Margaret C. Herbert 2018 Family Irrevocable GST Trust. Read SEC document |
| November 21, 2022 Filed Mar 13, 2023 20:51 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GiftCommon Stock | 24,115 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-031810 · tm239130-3_4seq1.xml · nonDerivative · entry 21 Herbert Timothy P. · CIK 0001737136 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,561 Read SEC document |
| November 21, 2022 Filed Mar 13, 2023 20:51 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GiftCommon Stock | 12,231 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-031810 · tm239130-3_4seq1.xml · nonDerivative · entry 20 Herbert Timothy P. · CIK 0001737136 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Indirect · By trust Disclosed balance after: 119,971 F8 · ownership.nature: Securities held by the Timothy P. Herbert 2018 Family Continuation Trust c/u the Timothy P. Herbert 2018 Grantor Retained Annuity Trust. Read SEC document |
| November 21, 2022 Filed Mar 13, 2023 20:51 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GiftCommon Stock | 36,346 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-031810 · tm239130-3_4seq1.xml · nonDerivative · entry 19 Herbert Timothy P. · CIK 0001737136 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Indirect · By GRAT Disclosed balance after: 0 F7 · ownership.nature: Securities held by the Timothy P. Herbert 2020 Grantor Retained Annuity Trust. Read SEC document |
| November 08, 2022 Filed Feb 10, 2023 23:36 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GiftCommon Stock | 2,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-018715 · tm236006-2_4seq1.xml · nonDerivative · entry 1 Herbert Timothy P. · CIK 0001737136 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Indirect · By family trust Disclosed balance after: 20,641 F1 · ownership.nature: Shares held by the Timothy P. Herbert 2013 Family Irrevocable GST Trust U/A/D November 27, 2013. Read SEC document |
| October 11, 2022 Filed Oct 13, 2022 22:31 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionStock Option (Right to Buy) · Derivative | 42 | $0.00 Strike: $42.15 | $0.00 |
DisclosureSEC source: 0001104659-22-108559 · tm2228171-1_4seq.xml · derivative · entry 10 Herbert Timothy P. · CIK 0001737136 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,958 Underlying: Common Stock · 42 shares Expires 2028-12-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: The option vested and became exercisable as to 25% of the underlying shares on the first anniversary of December 18, 2018 and the remaining 75% of the underlying shares have vested or will vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates. Read SEC document |
| October 11, 2022 Filed Oct 13, 2022 22:31 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionStock Option (Right to Buy) · Derivative | 41,216 | $0.00 Strike: $0.94 | $0.00 |
DisclosureSEC source: 0001104659-22-108559 · tm2228171-1_4seq.xml · derivative · entry 9 Herbert Timothy P. · CIK 0001737136 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 41,216 shares Expires 2027-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option is fully vested and exercisable. F6 · balance_after: Following the reported transactions, there are no remaining options held under this grant by the Reporting Person, either directly or indirectly. Read SEC document |
| October 11, 2022 Filed Oct 13, 2022 22:31 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionStock Option (Right to Buy) · Derivative | 27,529 | $0.00 Strike: $10.38 | $0.00 |
DisclosureSEC source: 0001104659-22-108559 · tm2228171-1_4seq.xml · derivative · entry 8 Herbert Timothy P. · CIK 0001737136 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,252 Underlying: Common Stock · 27,529 shares Expires 2028-04-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option is fully vested and exercisable. F5 · derivative.expiration_date: This option grant was previously reported as having an expiration date of April 8, 2028, which has been revised herein. Read SEC document |
| October 11, 2022 Filed Oct 13, 2022 22:31 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionCommon Stock | 42 | $42.15 | $1,770.30 |
DisclosureSEC source: 0001104659-22-108559 · tm2228171-1_4seq.xml · nonDerivative · entry 3 Herbert Timothy P. · CIK 0001737136 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 159,937 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 11, 2022 Filed Oct 13, 2022 22:31 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionCommon Stock | 41,216 | $0.94 | $38,743.04 |
DisclosureSEC source: 0001104659-22-108559 · tm2228171-1_4seq.xml · nonDerivative · entry 2 Herbert Timothy P. · CIK 0001737136 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 159,895 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 11, 2022 Filed Oct 13, 2022 22:31 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionCommon Stock | 27,529 | $10.38 | $285,751.02 |
DisclosureSEC source: 0001104659-22-108559 · tm2228171-1_4seq.xml · nonDerivative · entry 1 Herbert Timothy P. · CIK 0001737136 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,679 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 11, 2022 Filed Mar 13, 2023 20:51 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GiftCommon Stock | 35,117 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-031810 · tm239130-3_4seq1.xml · nonDerivative · entry 18 Herbert Timothy P. · CIK 0001737136 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Indirect · By GRAT Disclosed balance after: 36,346 F7 · ownership.nature: Securities held by the Timothy P. Herbert 2020 Grantor Retained Annuity Trust. Read SEC document |
| October 11, 2022 Filed Mar 13, 2023 20:51 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GiftCommon Stock | 35,117 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-031810 · tm239130-3_4seq1.xml · nonDerivative · entry 17 Herbert Timothy P. · CIK 0001737136 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,446 Read SEC document |
| April 18, 2022 Filed Apr 22, 2022 23:56 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionStock Option (Right to Buy) · Derivative | 8,196 | $0.00 Strike: $1.14 | $0.00 |
DisclosureSEC source: 0001104659-22-049152 · tm2213386-1_4seq1.xml · derivative · entry 8 Herbert Timothy P. · CIK 0001737136 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,196 shares Expires 2023-09-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option is fully vested and exercisable. F6 · balance_after: Following the reported transactions, there are no remaining options held under this grant by the Reporting Person, either directly or indirectly. Read SEC document |
| April 18, 2022 Filed Apr 22, 2022 23:56 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionStock Option (Right to Buy) · Derivative | 9,221 | $0.00 Strike: $1.47 | $0.00 |
DisclosureSEC source: 0001104659-22-049152 · tm2213386-1_4seq1.xml · derivative · entry 7 Herbert Timothy P. · CIK 0001737136 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,221 shares Expires 2022-05-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option is fully vested and exercisable. F5 · derivative.expiration_date: This option grant was previously reported as having an expiration date of April 30, 2022, which has been revised herein. F6 · balance_after: Following the reported transactions, there are no remaining options held under this grant by the Reporting Person, either directly or indirectly. Read SEC document |
| April 18, 2022 Filed Apr 22, 2022 23:56 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionCommon Stock | 8,196 | $1.14 | $9,343.44 |
DisclosureSEC source: 0001104659-22-049152 · tm2213386-1_4seq1.xml · nonDerivative · entry 2 Herbert Timothy P. · CIK 0001737136 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Indirect · By family trust Disclosed balance after: 22,641 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · ownership.nature: Shares held by the Timothy P. Herbert 2013 Family Irrevocable GST Trust U/A/D November 27, 2013. Read SEC document |
| April 18, 2022 Filed Apr 22, 2022 23:56 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionCommon Stock | 9,221 | $1.47 | $13,554.87 |
DisclosureSEC source: 0001104659-22-049152 · tm2213386-1_4seq1.xml · nonDerivative · entry 1 Herbert Timothy P. · CIK 0001737136 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Indirect · By family trust Disclosed balance after: 14,445 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · ownership.nature: Shares held by the Timothy P. Herbert 2013 Family Irrevocable GST Trust U/A/D November 27, 2013. Read SEC document |
| March 29, 2022 Filed Mar 30, 2022 00:31 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 8,427 | $252.37 | $2,126,721.99 |
DisclosureSEC source: 0001104659-22-039633 · tm2210731-1_4seq1.xml · nonDerivative · entry 10 Herbert Timothy P. · CIK 0001737136 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Indirect · By family trust Disclosed balance after: 22,875 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F10 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $252.095 to $252.935. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F6 · ownership.nature: Shares held by the Margaret C. Herbert 2018 Family Irrevocable GST Trust. Read SEC document |
| March 29, 2022 Filed Mar 30, 2022 00:31 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 6,280 | $251.41 | $1,578,854.80 |
DisclosureSEC source: 0001104659-22-039633 · tm2210731-1_4seq1.xml · nonDerivative · entry 9 Herbert Timothy P. · CIK 0001737136 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Indirect · By family trust Disclosed balance after: 31,302 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F9 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $251.01 to $251.85. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F6 · ownership.nature: Shares held by the Margaret C. Herbert 2018 Family Irrevocable GST Trust. Read SEC document |
| March 29, 2022 Filed Mar 30, 2022 00:31 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 82,709 | $250.27 | $20,699,581.43 |
DisclosureSEC source: 0001104659-22-039633 · tm2210731-1_4seq1.xml · nonDerivative · entry 8 Herbert Timothy P. · CIK 0001737136 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Indirect · By family trust Disclosed balance after: 37,582 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $250.00 to $250.995. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F6 · ownership.nature: Shares held by the Margaret C. Herbert 2018 Family Irrevocable GST Trust. Read SEC document |
| March 29, 2022 Filed Mar 30, 2022 00:31 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 2,051 | $252.20 | $517,262.20 |
DisclosureSEC source: 0001104659-22-039633 · tm2210731-1_4seq1.xml · nonDerivative · entry 5 Herbert Timothy P. · CIK 0001737136 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,150 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $252.01 to $252.522. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 29, 2022 Filed Mar 30, 2022 00:31 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 2,795 | $251.46 | $702,830.70 |
DisclosureSEC source: 0001104659-22-039633 · tm2210731-1_4seq1.xml · nonDerivative · entry 4 Herbert Timothy P. · CIK 0001737136 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,201 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $251.01 to $251.85. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 29, 2022 Filed Mar 30, 2022 00:31 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 22,913 | $250.36 | $5,736,498.68 |
DisclosureSEC source: 0001104659-22-039633 · tm2210731-1_4seq1.xml · nonDerivative · entry 3 Herbert Timothy P. · CIK 0001737136 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,996 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $250.00 to $250.99. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 29, 2022 Filed Mar 13, 2023 20:56 UTC Amendment | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 8,017 | $252.39 | $2,023,410.63 |
DisclosureSEC source: 0001104659-23-031817 · tm239130-1_4aseq1.xml · nonDerivative · entry 4 Herbert Timothy P. · CIK 0001737136 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,773 F9 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $252.10 to $252.935. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F6 · balance_after: The amount of securities listed in Column 5 reflects the total shares held following the transaction based on reference to the total reported in the Reporting Person's Form 4/A related to transactions originally reported on March 21, 2022 and that was filed on March 13, 2023. Read SEC document |
| March 29, 2022 Filed Mar 13, 2023 20:56 UTC Amendment | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 1,465 | $251.92 | $369,062.80 |
DisclosureSEC source: 0001104659-23-031817 · tm239130-1_4aseq1.xml · nonDerivative · entry 3 Herbert Timothy P. · CIK 0001737136 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Indirect · By trust Disclosed balance after: 103,658 F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $251.85 to $252.10. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F7 · ownership.nature: Securities held by the Timothy P. Herbert 2018 Family Continuation Trust c/u the Timothy P. Herbert 2018 Grantor Retained Annuity Trust. Read SEC document |
| March 29, 2022 Filed Mar 13, 2023 20:56 UTC Amendment | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 13,619 | $251.06 | $3,419,186.14 |
DisclosureSEC source: 0001104659-23-031817 · tm239130-1_4aseq1.xml · nonDerivative · entry 2 Herbert Timothy P. · CIK 0001737136 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Indirect · By trust Disclosed balance after: 105,123 F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $250.78 to $251.77. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F6 · balance_after: The amount of securities listed in Column 5 reflects the total shares held following the transaction based on reference to the total reported in the Reporting Person's Form 4/A related to transactions originally reported on March 21, 2022 and that was filed on March 13, 2023. F7 · ownership.nature: Securities held by the Timothy P. Herbert 2018 Family Continuation Trust c/u the Timothy P. Herbert 2018 Grantor Retained Annuity Trust. Read SEC document |
| March 29, 2022 Filed Mar 13, 2023 20:56 UTC Amendment | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 74,315 | $250.20 | $18,593,613.00 |
DisclosureSEC source: 0001104659-23-031817 · tm239130-1_4aseq1.xml · nonDerivative · entry 1 Herbert Timothy P. · CIK 0001737136 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Indirect · By family trust Disclosed balance after: 40,990 F1 · security: This Form 4 amends and restates the previously reported sale transactions made by the Margaret C. Herbert 2018 Family Irrevocable GST Trust that occurred on March 29, 2022 in order to re-allocate such sales between three different sellers that are considered beneficially owned by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $250.00 to $250.78. The reporting person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · balance_after: The amount of securities listed in Column 5 reflects the total shares held following the transaction owned by the Margaret C. Herbert 2018 Family Irrevocable GST Trust, by reference to the total reported in the Reporting Person's Form 4 filed on March 13, 2023. The total has increased from such Form 4 as a result of the prior overstatement of the sales by such trust on March 29, 2022 by 23,101 shares, which is corrected herein. F4 · ownership.nature: Shares held by the Margaret C. Herbert 2018 Family Irrevocable GST Trust. Read SEC document |
| March 28, 2022 Filed Mar 30, 2022 00:31 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 2,542 | $250.00 | $635,500.00 |
DisclosureSEC source: 0001104659-22-039633 · tm2210731-1_4seq1.xml · nonDerivative · entry 7 Herbert Timothy P. · CIK 0001737136 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Indirect · By family trust Disclosed balance after: 120,291 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $250.00 to $250.01. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F6 · ownership.nature: Shares held by the Margaret C. Herbert 2018 Family Irrevocable GST Trust. Read SEC document |
| March 28, 2022 Filed Mar 30, 2022 00:31 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 1,546 | $250.00 | $386,500.00 |
DisclosureSEC source: 0001104659-22-039633 · tm2210731-1_4seq1.xml · nonDerivative · entry 2 Herbert Timothy P. · CIK 0001737136 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,909 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $250.00 to $250.01. The reporting person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 25, 2022 Filed Mar 30, 2022 00:31 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 42 | $250.00 | $10,500.00 |
DisclosureSEC source: 0001104659-22-039633 · tm2210731-1_4seq1.xml · nonDerivative · entry 6 Herbert Timothy P. · CIK 0001737136 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Indirect · By family trust Disclosed balance after: 122,833 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F6 · ownership.nature: Shares held by the Margaret C. Herbert 2018 Family Irrevocable GST Trust. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.